Moreover, CD19 CART enhanced the proliferation of coinfused CAR T-cells targeting solid tumor antigens, like guanylyl cyclase C (GCC), which is expressed by 70% to 80% of CRC metastases. This evidence concerns the gene CD19 and colorectal carcinoma.